PERSPECTA

News from every angle

← Back to headlines

Summit Therapeutics Claims Lead Over Merck in Cancer Drug Development

Biotechnology firm Summit Therapeutics reports promising clinical data suggesting its oncology treatment outperforms Merck's competing cancer therapy.

3 Sept, 16:00 — 3 Sept, 16:00
PostShare

Sources

Showing 1 of 1 sources
Barron'sHigh2d ago

Summit Therapeutics Says It Is Beating Merck With Its Cancer Drug - Barron's

Summit Therapeutics Says It Is Beating Merck With Its Cancer Drug  Barron's

Read full article →

Related Stories

US Envoys Hold Extended Talks With Putin on Ukraine Peace Plans

1h ago

European Central Banks Shift Gold Reserves Out of United States

4h ago

Trump Threatens Trade Restrictions Over Federal Reserve Rate Decisions

8h ago

PM Modi Defends India’s 7.8% GDP Growth Amid Opposition Criticism

9h ago